F Star Therapeutics Inc Asset Turnover Ratio (FSTX), as of third quarter 2022, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
F star Therapeutics Inc   (NASDAQ: FSTX)
 

F Star Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

F Star Therapeutics Inc asset turnover ratio, the ability of F Star Therapeutics Inc 's assets to generate revenue in the third quarter 2022, increased sequentially to 0.2 in the third quarter (Sep 30 2022), FSTX's balance sheet remain strong.

Within sector F star Therapeutics Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2022 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FSTX Asset Turnover Ratio (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Asset Change -26.62 % -17.48 % 117.73 % 93.4 % 325.74 %
Y / Y Revenue Change 49.8 % - -12.55 % 10635.58 % -91.83 %
Asset Turnover Ratio (TTM) 0.2 - 0.18 0.21 0.04
FSTX's Total Ranking # # # # #
Seq. Asset Change -17.57 % -11.28 % -7.96 % 9.02 % -7.3 %
Seq. Revenue Change - - -85.42 % 2230.09 % -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




FSTX Company Profile • Back to FSTX Efficiency Comparisons • Compare FSTX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2022 Assets at quarter ending Sep 30 2022
Natera Inc   0.70 $ 775.998  Millions$ 1,114.310  Millions
Merit Medical Systems Inc  0.69 $ 1,136.058  Millions$ 1,635.573  Millions
Retractable Technologies Inc  0.69 $ 140.407  Millions$ 202.167  Millions
Paratek Pharmaceuticals Inc   0.69 $ 116.507  Millions$ 168.761  Millions
Nephros Inc   0.69 $ 10.217  Millions$ 14.867  Millions
Journey Medical Corp  0.68 $ 75.220  Millions$ 109.956  Millions
Amphastar Pharmaceuticals Inc   0.68 $ 484.851  Millions$ 709.545  Millions
Davita Inc   0.68 $ 11,636.973  Millions$ 17,067.718  Millions
Ethema Health Corporation   0.68 $ 4.475  Millions$ 6.593  Millions
Labcorp Holdings Inc   0.68 $ 13,745.500  Millions$ 20,335.725  Millions
Universe Pharmaceuticals Inc  0.67 $ 40.143  Millions$ 59.540  Millions
Paragon 28 inc   0.67 $ 172.650  Millions$ 256.321  Millions
Axogen inc   0.67 $ 133.957  Millions$ 199.413  Millions
Atrion Corporation  0.67 $ 180.944  Millions$ 271.543  Millions
Strata Skin Sciences Inc  0.66 $ 34.616  Millions$ 52.126  Millions
Neurocrine Biosciences Inc   0.66 $ 1,388.700  Millions$ 2,091.525  Millions
Syneos Health Inc   0.66 $ 5,406.599  Millions$ 8,238.877  Millions
Align Technology inc   0.65 $ 3,864.219  Millions$ 5,902.111  Millions
Vericel Corporation  0.65 $ 159.262  Millions$ 244.206  Millions
Q Biomed inc   0.65 $ 0.377  Millions$ 0.579  Millions
Agilent Technologies inc   0.65 $ 6,848.000  Millions$ 10,544.000  Millions
Iradimed Corporation  0.65 $ 50.312  Millions$ 77.636  Millions
Luna Innovations Inc  0.65 $ 90.744  Millions$ 140.508  Millions
Clearside Biomedical Inc   0.65 $ 26.684  Millions$ 41.348  Millions
Myovant Sciences Ltd   0.64 $ 333.323  Millions$ 517.102  Millions
Abiomed Inc   0.64 $ 1,074.096  Millions$ 1,666.613  Millions
Kaya Holdings Inc   0.64 $ 0.756  Millions$ 1.174  Millions
Marpai Inc  0.64 $ 22.609  Millions$ 35.211  Millions
Incyte Corporation  0.64 $ 3,330.788  Millions$ 5,204.206  Millions
Penumbra Inc  0.64 $ 829.928  Millions$ 1,298.831  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.